January 6, 2026 · Form 4 insider transaction
Poradosu Enrique bought 150,000 shares of Nuvectis Pharma, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 3 days after the transaction.
The 150,000 shares of restricted common stock will vest in equal annual installments over three years beginning on the first anniversary of the grant date subject to Mr. Poradosu's continued service on such dates.; Includes shares of restricted common stock.